PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database

INTRODUCTION: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9Is) were associated with a risk of neurocognitive adverse drug reactions (ADRs). OBJECTIVE: We aimed to investigate the occurrence of neuropsychiatric ADRs related to PCSK9Is. METHODS: We analyzed Individual Case Safety Rep...

Descripción completa

Detalles Bibliográficos
Autores principales: di Mauro, Gabriella, Zinzi, Alessia, Scavone, Cristina, Mascolo, Annamaria, Gaio, Mario, Sportiello, Liberata, Ferrajolo, Carmen, Rafaniello, Concetta, Rossi, Francesco, Capuano, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892743/
https://www.ncbi.nlm.nih.gov/pubmed/33351170
http://dx.doi.org/10.1007/s40264-020-01021-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892743/
https://www.ncbi.nlm.nih.gov/pubmed/33351170
http://dx.doi.org/10.1007/s40264-020-01021-3

Ejemplares similares